NAPLEX Passing Standards and MPJE Blueprint – October 2023 Implementation
2.
Drug Enforcement Administration (DEA) Submitted Final Rule to the Office of Management and Budget (OMB) regarding the Temporary Extension of COVID-19 Telemedicine Flexibilities for the Prescribing of Controlled Substances
3.
FDA Correspondence to NABP Regarding Compounding of Semaglutide